F De Vries

Summary

Affiliation: Utrecht University
Country: The Netherlands

Publications

  1. pmc Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study
    M E L Arbouw
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Universiteit Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
    Osteoporos Int 22:2197-204. 2011
  2. pmc Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States
    T P Khong
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Universiteitsweg 99, Utrecht, The Netherlands
    Calcif Tissue Int 91:24-31. 2012
  3. pmc Fracture rate in patients with myasthenia gravis: the general practice research database
    S Pouwels
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, The Netherlands
    Osteoporos Int 24:467-76. 2013
  4. pmc Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures
    A Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Osteoporos Int 23:861-9. 2012
  5. pmc Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    S Pouwels
    Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
    Osteoporos Int 22:903-10. 2011
  6. pmc The risk of fracture in patients with multiple sclerosis: the UK general practice research database
    Marloes T Bazelier
    Utrecht Institute of Pharmaceutical Sciences, Utrecht University, The Netherlands
    J Bone Miner Res 26:2271-9. 2011
  7. doi request reprint Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study
    Arief Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
    Stroke 43:3225-9. 2012
  8. pmc A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis
    Marloes T Bazelier
    Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
    Neurology 79:922-8. 2012
  9. pmc Knee arthroplasty and risk of hip fracture: a population-based, case-control study
    Arief Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Calcif Tissue Int 90:144-50. 2012
  10. doi request reprint Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
    F De Vries
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, The Netherlands
    Osteoporos Int 20:1989-98. 2009

Collaborators

Detail Information

Publications26

  1. pmc Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study
    M E L Arbouw
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Universiteit Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
    Osteoporos Int 22:2197-204. 2011
    ..Concomitant use of antidepressants further increased this risk. Fracture risk assessment may be warranted in elderly users of dopaminergic drugs...
  2. pmc Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States
    T P Khong
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Universiteitsweg 99, Utrecht, The Netherlands
    Calcif Tissue Int 91:24-31. 2012
    ..8 % and 8.2 %. During the next phase of the IMI-PROTECT study, a comparison with individual patient data will show whether this approach is valid...
  3. pmc Fracture rate in patients with myasthenia gravis: the general practice research database
    S Pouwels
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, The Netherlands
    Osteoporos Int 24:467-76. 2013
    ..Overall fracture risk is not statistically increased compared with age- and gender-matched controls irrespective of glucocorticoid use, but was increased in those using antidepressants, anxiolytics or anticonvulsants...
  4. pmc Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures
    A Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Osteoporos Int 23:861-9. 2012
    ..The FRAX tool has been calibrated to the entire Dutch population, using nationwide (hip) fracture incidence rates and mortality statistics from the Netherlands. Data used for the Dutch model are described in this paper...
  5. pmc Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    S Pouwels
    Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
    Osteoporos Int 22:903-10. 2011
    ..Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causal relationship between PPI use and hip fracture risk...
  6. pmc The risk of fracture in patients with multiple sclerosis: the UK general practice research database
    Marloes T Bazelier
    Utrecht Institute of Pharmaceutical Sciences, Utrecht University, The Netherlands
    J Bone Miner Res 26:2271-9. 2011
    ..It is concluded that MS is associated with an increased risk of fracture. Fracture risk assessment may be indicated in patients with MS, especially those prescribed GCs or antidepressants...
  7. doi request reprint Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study
    Arief Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
    Stroke 43:3225-9. 2012
    ..However, timing of stroke in THR patients compared with matched controls and influence of drug use remain unknown. The objective of this study was to determine timing of stroke in patients with THR compared with matched control subjects...
  8. pmc A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis
    Marloes T Bazelier
    Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
    Neurology 79:922-8. 2012
    ..To derive a simple score for estimating the long-term risk of osteoporotic and hip fracture in individual patients with MS...
  9. pmc Knee arthroplasty and risk of hip fracture: a population-based, case-control study
    Arief Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Calcif Tissue Int 90:144-50. 2012
    ..We found that KAs are associated with a 54% increased risk of hip fracture, in particular among adult patients aged <71 years old. Fracture risk assessment could be considered in patients who are about to undergo a KA...
  10. doi request reprint Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
    F De Vries
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, The Netherlands
    Osteoporos Int 20:1989-98. 2009
    ..Positive associations were observed for any hip and vertebral fracture. The effect size was modest; however, the significance lies in the widespread prescribing of acid suppressants...
  11. pmc Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension
    Frank De Vries
    Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Pharmacotherapy, Universiteit Utrecht, Utrecht, The Netherlands
    Br J Clin Pharmacol 65:580-6. 2008
    ....
  12. ncbi request reprint Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study
    F De Vries
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
    J Intern Med 261:170-7. 2007
    ..Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of this increased risk has not been widely studied...
  13. pmc Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands
    F De Vries
    Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Universiteit Utrecht, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands
    Calcif Tissue Int 80:69-75. 2007
    ....
  14. pmc Use of anti-depressants and the risk of fracture of the hip or femur
    M W M van den Brand
    Department of Geriatric Medicine, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
    Osteoporos Int 20:1705-13. 2009
    ..This should be considered when prescribing anti-depressants to patients...
  15. doi request reprint Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study
    A Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Eur J Neurol 19:1007-14. 2012
    ..Multiple sclerosis (MS) has been associated with increased mortality rates. However, influence of lifestyle parameters remains unknown, and inconsistencies exist regarding findings for causes of death...
  16. doi request reprint Risk of fracture in patients with Parkinson's disease
    S Pouwels
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Universiteitsweg, 99, 3584 CG Utrecht, Netherlands
    Osteoporos Int 24:2283-90. 2013
    ....
  17. pmc Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study
    S Pouwels
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    Osteoporos Int 20:1499-506. 2009
    ..Furthermore, no evidence for a dose effect was found...
  18. ncbi request reprint Risk of fracture in patients with Guillain-Barré syndrome
    S Pouwels
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Universiteitsweg 99, 3584CG, Utrecht, Netherlands
    Osteoporos Int 25:1845-51. 2014
    ..No association with risk of fracture was observed for GBS patients compared with controls. Only GBS patients using pain treatment had a doubled risk of fracture...
  19. pmc Risk of fractures in patients with multiple sclerosis: a population-based cohort study
    M T Bazelier
    Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
    Neurology 78:1967-73. 2012
    ..To examine the risk of fracture in patients with multiple sclerosis (MS) compared with population-based controls...
  20. ncbi request reprint Severity of obstructive airway disease and risk of osteoporotic fracture
    F De Vries
    Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, The Netherlands
    Eur Respir J 25:879-84. 2005
    ..However, adequate adjustment for disease severity is essential when the association between the use of inhaled corticosteroids and risk of osteoporotic fracture is studied in observational research...
  21. doi request reprint Risk of fracture in patients with muscular dystrophies
    S Pouwels
    Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, Netherlands
    Osteoporos Int 25:509-18. 2014
    ..Patients with MD are at a 1.4-fold increased risk of fracture as compared with population-based control patients. Risk further increased among elderly and female patients and among patients exposed to oral glucocorticoids...
  22. doi request reprint Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement
    A Lalmohamed
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands
    J Thromb Haemost 11:642-50. 2013
    ..The objectives were to evaluate long-term VTE risk following THR/TKR compared with matched controls, and to investigate effect modification by prolonged outpatient vitamin K antagonist use...
  23. ncbi request reprint The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink
    P J H L Peeters
    Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
    J Thromb Haemost 12:444-51. 2014
    ..In patients with multiple sclerosis (MS), disability and autoinflammatory processes may result in an increased risk of venous thromboembolism (VTE) OBJECTIVE: To evaluate the risk of VTE associated with MS...
  24. pmc Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
    C Klop
    Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, The Netherlands
    Osteoporos Int 25:385-92. 2014
    ..However, the proportion of bisphosphonate-treated patients remained low...
  25. ncbi request reprint Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
    V Abbing-Karahagopian
    Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, P O Box 80 082, Utrecht, The Netherlands
    Eur J Clin Pharmacol 70:849-57. 2014
    ..The aim of this study was to describe the time trends in antidepressant prescribing in the last decade and the variation in the prevalence, calculated in a uniform manner, in seven European electronic healthcare databases...